MedTrace Logo

Improving Safety of Antivenom in People Bitten by Snakes

NCT00270777 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2008-06-05

No results posted yet for this study

Summary

A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, \& hydrocortisone (alone and in combination) to prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double blind, placebo-controlled trial.

Conditions

  • Snake Bites

Interventions

DRUG

adrenaline, promethazine, hydrocortisone

Sponsors & Collaborators

  • University of Kelaniya

    lead OTHER

Principal Investigators

  • Asita de Silva · University of Kelaniya

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Sri Lanka

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00270777 on ClinicalTrials.gov